Cargando…

Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines

Administration of AstraZeneca/Oxford and Johnson & Johnson/Janssen Covid-19 vaccines which use an adenovirus vector for DNA delivery has been associated with very rare thromboembolic complications coupled with an immune response to platelet factor 4 protein. The cause of this has not yet been id...

Descripción completa

Detalles Bibliográficos
Autor principal: Feldman, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722443/
https://www.ncbi.nlm.nih.gov/pubmed/35002021
http://dx.doi.org/10.1016/j.mehy.2021.110756